Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nature medicine
View this publicationNature medicine
View this publicationNAR genomics and bioinformatics
View this publicationBMJ open
View this publicationBriefings in bioinformatics
View this publicationDiagnostics (Basel, Switzerland)
View this publicationMolecular human reproduction
View this publicationInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
View this publicationFrontiers in genome editing
View this publicationNature communications
View this publicationJournal of medical virology
View this publication